The burden of comorbidities in pulmonary arterial hypertension

Patients with comorbidities are often excluded from clinical trials, limiting the evidence base for pulmonary arterial hypertension (PAH)-specific therapies. This review aims to discuss the effect of comorbidities on the diagnosis and management of PAH. The comorbidities discussed in this review (sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Irene M, Palazzini, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915052/
https://www.ncbi.nlm.nih.gov/pubmed/31857797
http://dx.doi.org/10.1093/eurheartj/suz205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915052/
https://www.ncbi.nlm.nih.gov/pubmed/31857797
http://dx.doi.org/10.1093/eurheartj/suz205

Ejemplares similares